Access Publication

Responding to the challenges of flow cytometry

Technical Evaluation of the Accellix Platform

Provide the following information and we’ll email you a copy of this publication:

*Required field

First Name*

Last Name*

Job Title*

Name of Institution*

Telephone

Email*

City*

State*

Country/Region*

Interest*

Cell Therapy Manufacturing QCStem Cell Transplant Enumeration & PhenotypingBlood Donor Phenotyping

I consent to receive occasional email communications from Accellix (e.g., product updates, technical resources, event announcements, promotions). I understand that I can unsubscribe at any time. View our Privacy Policy.

Please leave this field empty.

Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.

Access Publication

Technical Evaluation of the Accellix Platform

Provide the following information and we’ll email you a copy of this publication:

U.S. Office

Israel Office